Sort
23,748 grants matching “melanoma”
Human Immunology Core
$236,645Caryn Lerman · University Of Pennsylvania · P30 · FY2015 · CA
Investigating the role of the microbiota in enhancing memory T cell function during caloric restriction to promote melanoma control
$236,550Nicholas Collins · Weill Medical Coll Of Cornell Univ · R00 · FY2024 · CA
Cheng - Proj 2
$236,505Chao Cheng · Dartmouth College · P20 · FY2020 · GM
Neoplastic transformation of melanocytes by Grm1
$236,501Suzie Chen · Rutgers, The State Univ Of N.J. · R01 · FY2008 · CA
Targeting alfa 1beta1 integrin in cancer development
$236,484Cezary Marcinkiewicz · Temple Univ Of The Commonwealth · R01 · FY2006 · CA
Biostatistics and Bioinformatics Core
$236,460Phyllis A Gimotty · Wistar Institute · P50 · FY2022 · CA
Cutaneous Human Papillomavirus as a Novel Model of Viral Oncogenesis
$236,388Nicholas A Wallace · Kansas State University · P20 · FY2020 · GM
DCs Regulate Chemokine Responsiveness of Melanoma-Specific T Cells
$236,355Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P50 · FY2011 · CA
Characterization of the oncogenic potential of circRNAs in melanoma
$236,321Florian Karreth · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2022 · CA
Defining and targeting the immune-suppressive metabolic microenvironment of leptomeningeal melanoma metastases
$236,321Inna Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2022 · CA
Defining and targeting the epigenetic programs involved in melanoma development
$236,321Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2022 · CA
L-fucose-mediated enrichment of memory CD4+T cells and enhanced anti-melanoma immunity
$236,321Eric Kirk Lau · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2024 · CA
Multifunctional Nanoprobe for Early Appraisal of Immunotherapeutic Efficacy
$236,250Srikanth Singamaneni · Washington University · R21 · FY2021 · EB
Prediction and Treatment for Cancer Immunotherapy Induced Myocarditis
$236,250Hua Pan · Washington University · R21 · FY2022 · HL
Promoting Tumor Immunity by Cross-Linking B7-DC
$236,246Larry R Pease · Mayo Clinic Rochester · R56 · FY2008 · CA
Promoting Tumor Immunity by Cross-Linking B7-DC
$236,215Larry R Pease · Mayo Clinic Rochester · R01 · FY2006 · CA
Role of AhR/Arnt Signaling Pathway in Carcinogenesis
$236,196Rutgers The St Univ Of Nj New Brunswick · R01 · FY2004 · ES
Core B: Proteomics Core.
$236,084Peter Kent Jackson · Stanford University · P01 · FY2025 · CA
HSP70 as a Novel Therapeutic Target for Melanoma
$236,081Maureen E Murphy · Wistar Institute · P01 · FY2017 · CA
WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA
$236,030Matthew J Sikora · University Of Colorado Denver · R00 · FY2019 · CA
HSP70 as a Novel Therapeutic Target for Melanoma
$236,006Maureen E Murphy · Wistar Institute · P01 · FY2015 · CA
Mechanism and Inhibition of Collagenolytic Activity
$235,996Gregg B Fields · University Of Texas Hlth Science Center · R01 · FY2008 · CA
DC VACCINE TO ELICIT POLYSPECIFIC THI ANTI-TUMOR IMMUNIT
$235,979University Of Pittsburgh At Pittsburgh · P01 · FY2004 · CA
COMPUTATIONAL &LABORATORY STUDY OF P16/INK4 MUTATIONS
$235,961University Of Vermont &St Agric College · R01 · FY2004 · CA
COMPUTATIONAL &LABORATORY STUDY OF P16/INK4 MUTATIONS
$235,961University Of Vermont &St Agric College · R01 · FY2003 · CA